CoChat

IntEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): protocol for a randomised and controlled, multicentre, acceptability, feasibility and implementation trial

Open access
Taylor, Gemma, Aveyard, Paul, Bartlem, Kate, Shaw, Alison, Player, Jeremy, Metcalfe, Chris, Kessler, David, Munafò, Marcus · 2019 · Pilot and Feasibility Studies

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index; 6 of the 11 sources its claims cite were checked for support.

Abstract

BACKGROUND: People with depression/anxiety are twice as likely to smoke and are less responsive to standard tobacco treatments, leading to a reduced life expectancy of up to 13.6 years compared to people without depression/anxiety. However, this group of smokers is motivated to quit, and as a result of quitting smoking, their depression/anxiety is likely to improve. In England, people with depression/anxiety are referred to a primary care-based psychological therapies service known as 'Improving Access to Psychological Therapies' (IAPT), which could offer smoking cessation treatment as part of usual care but currently does not. In this study, we aim (1) to establish the feasibility and acceptability of delivering a smoking cessation treatment alongside IAPT usual care and (2) to establish the feasibility of a multi-centre randomised trial to compare the combined smoking cessation and IAPT treatment to usual IAPT treatment alone. METHODS: A randomised and controlled, multi-centre trial to test the acceptability, feasibility and implementation of smoking cessation treatment as offered alongside usual IAPT care, compared to usual care alone, with nested qualitative methods. We will include adult daily smokers with depression/anxiety, who would like help to quit smoking and are about to start IAPT treatment. Follow-up will be conducted at 3-months after baseline. The main outcome will be retention in the smoking cessation treatment. Secondary outcomes are smoking-related (biochemically-verified 7-day point prevalence smoking cessation, number of cigarettes smoked per day, Heaviness of Smoking Index), mental health-related (PHQ-9), service-related (number of 'Did Not Attends', number of planned and completed IAPT sessions), acceptability and feasibility (participant and clinician acceptability and satisfaction of intervention as assessed by questionnaires and qualitative interviews, interviews will also explore acceptability and feasibility of data collection procedures and impact of smoking cessation treatment on usual care and mental health recovery) and implementation-related (intervention delivery checklist, qualitative analysis of intervention delivery). DISCUSSION: If the intervention is shown to be acceptable, feasible and suitably implemented, we can conduct a randomised controlled trial. In a future trial, we would examine whether adding smoking cessation treatment increases smoking abstinence and improves depression and anxiety more than usual care, which would lead to long-term health improvement. TRIAL REGISTRATION: ISRCTN99531779.

Overview

CoChat Summary

## TL;DR

ESCAPE is a protocol for a multicentre randomized feasibility trial testing whether smoking cessation treatment can be integrated into usual IAPT psychological care for adults with depression/anxiety who smoke. The study is designed to assess acceptability, feasibility, and implementation, not definitive clinical effectiveness.

## Key findings

  • The trial will recruit adult daily smokers with depression/anxiety who are about to start IAPT treatment and want help quitting smoking.
  • The planned sample size is 157 at baseline, with an assumption that 100 participants will be available at follow-up and about 36% will be lost to follow-up.
  • The main feasibility outcome is retention in smoking cessation treatment; the protocol states the study is powered to estimate that 40% or more of intervention participants will continue treatment, with a 95% confidence interval of 26% to 55% if the true rate is 40%.
  • A secondary smoking outcome is biochemically verified 7-day point prevalence abstinence using exhaled carbon monoxide of < 10 ppm at 3-month follow-up.

## Methods

  • Design: Randomised, controlled, multicentre feasibility trial with nested qualitative research; 1:1 allocation to intervention vs usual care, stratified by site and blocked.
  • Sample/setting: Two UK IAPT sites (Bristol and Oxford); participants are adults (18+) with depression/anxiety, daily smokers for at least 1 year, interested in quitting, and about to start IAPT. PWPs delivering the intervention must have at least 2 years of IAPT experience.
  • Analysis: Quantitative analyses in Stata, with regression models adjusting for study site, patient’s PWP, and baseline GAD-7/PHQ-9 scores; qualitative data analyzed thematically in NVivo.

## Limitations

  • The paper itself states this is a feasibility study, so effect estimates “will be too imprecise to support definitive conclusions.”
  • The study is not large enough to explore some implementation differences, including the impact of CO-monitoring not being used at one site; this is stated in the discussion.
  • Evident from the text: the protocol has no results yet, so claims are limited to planned methods and anticipated outcomes rather than observed findings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40814-018-0385-2

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Fig. 1 Flow chart of study events
Fig. 1 Flow chart of study eventsCC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 6 Not valid · 2 Not checked · 12 Own results and interpretations

16 more claims

Create a free account to see all 21 claims and to verify the 5 references still open.

See all claims — free account

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 3

  1. Office for National Statistics. General lifestyle survey: chapter 1. smoking. London, UK. 2014.
  2. Taylor, G, Davies, N, Thomas, K, Rai, D, Jones, T, Windmeijer, F, Szatkowski, L, Martin, R, Munafò M & Taylor, A. (2018) Prescribing prevalence, long-term effectiveness, and mental health safety of varenicline and nicotine replacement therapy in patients with mental disorders: A prospective cohort study of electronic medical records. (Under review).
  3. McEwen A. Standard treatment programme: a guide to behavioural support for smoking cessation; 2014.

Cited by

See all 13

Metadata

Authors
Taylor, G., Aveyard, P., Bartlem, K., Shaw, A., Player, J., Metcalfe, C., Kessler, D., & Munafò, M.
Affiliations
  • University of Bath (GB)
  • University of Oxford (GB)
  • Hunter New England Local Health District (AU)
  • University of Bristol (GB)
  • At Bristol (GB)
Corresponding author
Taylor, Gemma
Venue
Pilot and Feasibility Studies
Published
2019-01-22
Volume
5
Issue
1
Pages
16-16
ISSN
2055-5784 (ISSN-L)
OpenAlex
W2912932241
Cited by
11
References
39
Citations by year
2025: 2 · 2024: 2 · 2022: 3 · 2021: 3 · 2020: 1
FWCI
1.20
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Pilot and Feasibility Studies (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
  • Explore Bristol Research (submittedVersion, cc-by)
Funders
Cancer Research UK (C56067/A21330)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
smoking cessation, depression, anxiety, Improving Access to Psychological Therapies, treatment acceptability, treatment feasibility, implementation, smoking abstinence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IntEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): protocol for a randomised and controlled, multicentre, acceptability, feasibility and implementation trial. https://app.cochat.ai/papers/10.1186/s40814-018-0385-2
The paper
Taylor, G., Aveyard, P., Bartlem, K., Shaw, A., Player, J., Metcalfe, C., Kessler, D., & Munafò, M. (2019). IntEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): protocol for a randomised and controlled, multicentre, acceptability, feasibility and implementation trial. Pilot and Feasibility Studies. https://doi.org/10.1186/s40814-018-0385-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.